Is Illumina’s (ILMN) Deeper IDT DRAGEN Tie-Up Quietly Rewriting Its Oncology Software Edge?

Endpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meeting

Endpoints NewsDimension seeks up to $750M for third life sciences fund after string of success

Endpoints NewsElevance talks 'practical' AI

Endpoints NewsMammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once again

FierceBiotechAutobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2

Lonza NewsLonza, Stipple Bio Sign ADC Licensing Deal - Contract Pharma

Endpoints NewsHikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug

CellPaleogenomes reveal the evolutionary relationship between modern and cave lions

Endpoints NewsLilly, Boehringer retrench in Germany on proposed health spending cuts

Endpoints NewsSupreme Court sides with Hikma in 'skinny label' case

FierceBiotechAs China biotech crackdown calls reverberate in Washington, the pushback gets louder, too

BioWorldDeaths mar ADC’s confirmatory trial with Zynlonta in DLBCL